Innate Pharma (IPHA) has become technically an oversold stock now, which implies exhaustion of the h

Innate Pharma (IPHA) has become technically an oversold stock now, which implies exhaustion of the h

Innate Pharma (NASDAQ:IPHA) held its quarterly earnings conference call on Thursday. Below is the co

Companies Reporting Before The Bell • 111 (NASDAQ:YI) is projected to report earnings for its second

Innate Pharma (NASDAQ:IPHA) reported quarterly losses of $(0.24) per share which missed the analyst

Gainers Capricor Therapeutics (NASDAQ:CAPR) stock rose 94.8% to $8.2 during Friday's pre-market

Gainers BioVie (NASDAQ:BIVI) shares increased by 39.4% to $1.77 during Wednesday's regular sess

Gainers Bone Biologics (NASDAQ:BBLG) stock moved upwards by 17.7% to $1.07 during Wednesday's p

BTIG analyst Jeet Mukherjee maintains Innate Pharma (NASDAQ:IPHA) with a Buy and raises the pric

HC Wainwright & Co. analyst Swayampakula Ramakanth maintains Innate Pharma (NASDAQ:IPHA) with

Gainers Jin Medical International (NASDAQ:ZJYL) shares rose 58.1% to $3.4 during Monday's regul

Sobi and Innate Pharma partner for a Phase 3 trial of lacutamab targeting rare skin cancer, featurin

Gainers Jin Medical International (NASDAQ:ZJYL) stock rose 70.7% to $3.67 during Monday's pre-m

BKYI: -8% | BIO-key And Visualforma Win Contract To Strengthen Digital Identity Security For Portugu

Innate to advance lacutamab towards TELLOMAK-3 Phase 3 following the partnership with Sobi, a key st

Enrollment completed in the dose escalation of IPH4502-101 study, with preliminary data readout from

Lacutamab TELLOMAK-3 confirmatory Phase 3 trial in cutaneous T-cell lymphoma (CTCL) remains planned

Encouraging early results catalyze continued investigation in the MATISSE Phase 2 study evaluating I

HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates Innate Pharma (NASDAQ:IPHA) wit

Innate Pharma (NASDAQ:IPHA) reported quarterly losses of $(0.64) per share which beat the analyst co

BTIG analyst Jeet Mukherjee assumes Innate Pharma (NASDAQ:IPHA) with a Buy rating and announces

Companies Reporting Before The Bell • Creative Realities (NASDAQ:CREX) is expected to report quarte

  During Monday's session, 402 companies made new 52-week lows.

    On Monday, 524 stocks hit new 52-week lows.

  During the morning session on Thursday, 152 stocks hit new 52-week lows.

  Companies Reporting Before The Bell • Oxford Lane Capital (NASDAQ:OXLC) is estimated to report e

110 Biggest Movers From Yesterday

95 Stocks Moving In Monday's Mid-Day Session

Stocks That Hit 52-Week Lows On Monday

144 Biggest Movers From Friday

Stocks That Hit 52-Week Lows On Friday

Stocks That Hit 52-Week Lows On Thursday